Literature DB >> 17960571

Chondroitin sulfate prevents platelet derived growth factor-mediated phosphorylation of PDGF-Rbeta in normal human fibroblasts severely impairing mitogenic responses.

E Fthenou1, A Zafiropoulos, P Katonis, A Tsatsakis, N K Karamanos, G N Tzanakakis.   

Abstract

Platelet-derived growth factor (PDGF) is a major polypeptide mitogen for cells of mesenchymal origin such as fibroblasts. Chondroitin sulfate chains (CS), which are abundant in the extracellular matrix have been shown to physically interact with PDGF-BB modulating its biological function. The aim of the present study was to examine the involvement of CS on PDGF-BB induced proliferative responses and receptor activation in human lung fibroblasts. The addition of exogenous free CS chains caused a significant downregulation of the PDGF-BB mediated mitogenic and chemotactic responses. Similar results were obtained by the increase of endogenous CS biosynthesis after beta-D-xyloside treatment. Furthermore, removal of the membrane-bound CS chains by selective enzymatic treatment significantly increased the proliferative capacity of human fibroblasts. Analysis of PDGF-R phosphorylation in the presence of CS or beta-D-xyloside, revealed a reduction of PDGF-Rbeta phosphorylation in the tyrosine residue 1021. These results demonstrate, for the first time, that CS either soluble or surface bound downregulates the mitogenic responses of PDGF-BB in normal human lung fibroblasts through the reduction of PDGF-Rbeta phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17960571     DOI: 10.1002/jcb.21570

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  Biomaterials that regulate growth factor activity via bioinspired interactions.

Authors:  Gregory A Hudalla; William L Murphy
Journal:  Adv Funct Mater       Date:  2011-05-24       Impact factor: 18.808

2.  Influence of glycosaminoglycan identity on vocal fold fibroblast behavior.

Authors:  Andrea Carolina Jimenez-Vergara; Dany J Munoz-Pinto; Silvia Becerra-Bayona; Bo Wang; Alexandra Iacob; Mariah S Hahn
Journal:  Acta Biomater       Date:  2011-06-25       Impact factor: 8.947

Review 3.  How does the pathophysiological context influence delivery of bone growth factors?

Authors:  Xiaohua Yu; Darilis Suárez-González; Andrew S Khalil; William L Murphy
Journal:  Adv Drug Deliv Rev       Date:  2014-10-17       Impact factor: 15.470

4.  Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions.

Authors:  Abigail H Conrad; Yuntao Zhang; Elena S Tasheva; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

5.  Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis.

Authors:  Kornélia Baghy; Zsolt Horváth; Eszter Regős; Katalin Kiss; Zsuzsa Schaff; Renato V Iozzo; Ilona Kovalszky
Journal:  FEBS J       Date:  2013-03-25       Impact factor: 5.542

6.  Chondroitin sulfate synthase 1 enhances proliferation of glioblastoma by modulating PDGFRA stability.

Authors:  Wen-Chieh Liao; Chih-Kai Liao; To-Jung Tseng; Ying-Jui Ho; Ying-Ru Chen; Kuan-Hung Lin; Te-Jen Lai; Chyn-Tair Lan; Kuo-Chen Wei; Chiung-Hui Liu
Journal:  Oncogenesis       Date:  2020-02-04       Impact factor: 7.485

7.  Organotypic Cultures of Intervertebral Disc Cells: Responses to Growth Factors and Signaling Pathways Involved.

Authors:  Harris Pratsinis; Dimitris Kletsas
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

Review 8.  Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.

Authors:  Chiara Urbinati; Paola Chiodelli; Marco Rusnati
Journal:  Molecules       Date:  2008-11-06       Impact factor: 4.411

Review 9.  Glycosaminoglycan-based biomaterials for growth factor and cytokine delivery: Making the right choices.

Authors:  Daniel Hachim; Thomas E Whittaker; Hyemin Kim; Molly M Stevens
Journal:  J Control Release       Date:  2019-10-16       Impact factor: 9.776

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.